|
Dr_Dan ★★ Germany, 2012-05-29 11:56 (5144 d 16:44 ago) Posting: # 8623 Views: 3,170 |
|
|
Dear all We conducted an open label BE study with our test product against the European innovator product. Would it be possible to submit this study to get a marketing authorization in Canada? I see two problems: a) The study was not blinded (see 2.4.2 of the Canadian BE guideline), but I think there are good arguments against this demand b) The reference product was the European innovator product but this is also marketed in Canada. Has anyone experience with this situation? I am unable to find C.08.004 in the Food and Drug Regulations (C.R.C., c. 870) http://laws-lois.justice.gc.ca/eng/regulations/C.R.C.%2C_c._870/page-288.html#h-297 I am looking forward to your advice. Kind regards Dan — Kind regards and have a nice day Dr_Dan |
|
jag009 ★★★ NJ, 2012-05-30 20:13 (5143 d 08:27 ago) @ Dr_Dan Posting: # 8633 Views: 2,514 |
|
|
Hi Dr. Dan, 1) I don't think TPD (Canada) will enforce the blinded issue. We submitted US FDA open-label studies (BE and NDA) for Canadian filing and they were okay. 2) Are the names of the innovator product (Euro and Canada) the same? John Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut] |
|
Vijaya ☆ India, 2012-06-01 12:44 (5141 d 15:56 ago) @ Dr_Dan Posting: # 8648 Views: 2,444 |
|
|
❝ ❝ Has anyone experience with this situation? I am unable to find C.08.004 in the Food and Drug Regulations (C.R.C., c. 870) http://laws-lois.justice.gc.ca/eng/regulations/C.R.C.%2C_c._870/page-288.html#h-297 ❝ I am looking forward to your advice. ❝ Kind regards ❝ Dan Greetings to all ! Dear Dr.Dan, C.08.004 can be found in page no.: 1036 in C.R.C.,c.870 Hope it helps. Regards, Vijaya. |
|
Dr_Dan ★★ Germany, 2012-06-01 14:19 (5141 d 14:22 ago) @ Vijaya Posting: # 8650 Views: 2,425 |
|
|
Yes, you are right. I really need new glasses.... — Kind regards and have a nice day Dr_Dan |
